U.S. Stimulus Bill Lifts Asian Equities

Published 12/28/2020, 06:40 AM
JP225
-
HK50
-
SSEC
-
BABA
-

Trump signs stimulus/spending bill into law

With liquidity lower than usual and a dearth of meaningful news over the weekend, the presidential signing of the omnibus bill today has lifted sentiment in Asia. Most of the region is green, although the gains scale is modest, perhaps reflecting the holiday-thinned participation. As far as President Trump is concerned, there is still more work to be done on the stimulus bill. Both the Financial Times and Bloomberg are saying that the president has claimed that the GOP Senators and the Democrat-controlled House will vote on increasing the USD600 payment. Additionally, Section 230 (the social media content liability shield) would be repealed, and an investigation in voter fraud commenced. However, legally speaking, the bill is a done deal.

Asian markets are mostly in positive territory on Monday. The Nikkei 225 has risen 0.40%, with the Kospi rushing 0.70% higher out of the gates this morning. Singapore is 0.20% higher, Taipei has rallied 0.75% higher, with Kuala Lumpur jumping 0.80% and Jakarta up 0.15%. Only Manila is lagging regionally, down 1.30% in early trading.

China has shrugged off news that Ant Financial has been told to go back to basics by the PBOC this weekend. The threatened breakup coming after its parent Alibaba’s shares tanked in the US on Thursday after Chinese authorities announced investigations into its business practises. Not being listed on the mainland may have been a blessing in disguise for the Shanghai Composite and CSI 300, which are higher by 0.30% and 0.50% respectively. Hong Kong has weathered the storm as well, despite Alibaba (NYSE:BABA) being listed there. The Hang Seng has risen 0.35% today.

Australia and the United Kingdom are closed today for Boxing Day, but European equities should also catch the US stimulus tailwind and move higher. Sentiment should also receive a modest boost with the start of Covid-19 vaccinations across the Eurozone at the weekend.

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.